| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000111281 |
| P698 | PubMed publication ID | 8549424 |
| P2093 | author name string | Kagawa T | |
| Ikenaka K | |||
| P433 | issue | 3 | |
| P304 | page(s) | 127-136 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Developmental Neuroscience | Q15763713 |
| P1476 | title | Transgenic systems in studying myelin gene expression | |
| P478 | volume | 17 |
| Q73066534 | A transgenic mouse model for inducible and reversible dysmyelination |
| Q33958498 | Adeno-associated virus vectors: activity and applications in the CNS. |
| Q48569841 | Delayed and incomplete myelination in a transgenic mouse mutant with abnormal oligodendrocytes |
| Q36276665 | Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. |
| Q79356179 | Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons |
| Q52128603 | Disturbed oligodendrocyte development and recovery from hypomyelination in a c-myc transgenic mouse mutant. |
| Q37203101 | Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females |
| Q30500898 | Glial grafting for demyelinating disease. |
| Q46787360 | His36Pro point-mutated proteolipid protein retained in the endoplasmic reticulum of oligodendrocytes in the shaking pup. |
| Q57898448 | Human proteolipid protein (PLP) mediates winding and adhesion of phospholipid membranes but prevents their fusion |
| Q40658569 | Identification of Golli and myelin basic proteins in human brain during early development |
| Q34199635 | Molecular pathways of oligodendrocyte apoptosis revealed by mutations in the proteolipid protein gene |
| Q33787336 | New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies |
| Q37174777 | On the occurrence of hypomyelination in a transgenic mouse model: a consequence of the myelin basic protein promoter? |
| Q48579837 | Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. |
| Q52168267 | The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin. |
| Q36155932 | The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. |
| Q40691684 | Trafficking of PLP/DM20 and cAMP signaling in immortalized jimpy oligodendrocytes. |
| Q33921558 | Transcriptional control in myelinating glia: flavors and spices. |
| Q28513756 | Uncoupling of neuroinflammation from axonal degeneration in mice lacking the myelin protein tetraspanin-2 |
| Q74587444 | Understanding glial abnormalities associated with myelin deficiency in the jimpy mutant mouse |
| Q42798903 | Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant glioma cells |
Search more.